Concourse Financial Group Securities, Inc. Viking Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$19.98 - $29.49 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	SELL	$24.15 - $42.89 $59,167 - $105,080	-2,450 Closed	0 $0
Q4 2024 Feb 13, 2025	BUY	$38.28 - $78.03 $66,990 - $136,552	1,750 Added 250.0%	2,450 $98,000
Q3 2024 Oct 10, 2024	BUY	$49.84 - $70.47 $4,984 - $7,047	100 Added 16.67%	700 $44,000
Q2 2024 Jul 23, 2024	BUY	$47.39 - $80.2 $28,434 - $48,120	600 New	600 $31,000
Q1 2024 Apr 30, 2024	BUY	$17.4 - $94.5 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$9.24 - $19.64 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$10.92 - $16.0 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$10.92 - $16.0 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$14.84 - $24.79 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$2.72 - $9.4 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$2.55 - $3.89 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$2.11 - $3.15 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	SELL	$3.0 - $4.88 $600 - $976	-200 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$5.74 - $9.67 $1,148 - $1,934	200 New	200 $1,000
Q4 2020 Feb 02, 2021	SELL	$5.3 - $6.71 $408 - $516	-77 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.38 - $8.73 $491 - $672	77 New	77 $1,000
Q3 2019 Nov 13, 2019	SELL	$6.55 - $8.6 $504 - $662	-77 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$7.67 - $10.63 $291 - $403	-38 Reduced 33.04%	77 $1,000
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $295 - $387	-39 Reduced 25.32%	115 $1,000
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $1,102 - $2,496	154 New	154 $1,000
Q3 2018 Nov 13, 2018	BUY	$9.7 - $19.65 $0 - $0	0 New	0 $0

Others Institutions Holding VKTX

# of Institutions

445

Shares Held

66.7M

Call Options Held

7.79M

Put Options Held

3.25M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.03B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account